Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Cross-border outbreak of extensively drug-resistant tuberculosis linked to a university in Romania.

Popovici O, Monk P, Chemtob D, Chiotan D, Freidlin PJ, Groenheit R, Haanperä M, Homorodean D, Mansjö M, Robinson E, Rorman E, Smith G, Soini H, Van Der Werf MJ.

Epidemiol Infect. 2018 May;146(7):824-831. doi: 10.1017/S095026881800047X.

PMID:
29769160
2.

Evaluation of whole genome sequencing and software tools for drug susceptibility testing of Mycobacterium tuberculosis.

van Beek J, Haanperä M, Smit PW, Mentula S, Soini H.

Clin Microbiol Infect. 2019 Jan;25(1):82-86. doi: 10.1016/j.cmi.2018.03.041. Epub 2018 Apr 11.

PMID:
29653190
3.

A cluster of multidrug-resistant Mycobacterium tuberculosis among patients arriving in Europe from the Horn of Africa: a molecular epidemiological study.

Walker TM, Merker M, Knoblauch AM, Helbling P, Schoch OD, van der Werf MJ, Kranzer K, Fiebig L, Kröger S, Haas W, Hoffmann H, Indra A, Egli A, Cirillo DM, Robert J, Rogers TR, Groenheit R, Mengshoel AT, Mathys V, Haanperä M, Soolingen DV, Niemann S, Böttger EC, Keller PM; MDR-TB Cluster Consortium.

Lancet Infect Dis. 2018 Apr;18(4):431-440. doi: 10.1016/S1473-3099(18)30004-5. Epub 2018 Jan 8. Erratum in: Lancet Infect Dis. 2018 Jan 10;:.

4.

Trends and differences in tuberculosis incidences and clustering among natives in Denmark, Sweden and Finland: comparison of native incidences and molecular epidemiology among three low-incidence countries.

Pedersen MK, Lillebaek T, Andersen AB, Soini H, Haanperä M, Groenheit R, Jonsson J, Svensson E.

Clin Microbiol Infect. 2018 Jul;24(7):717-723. doi: 10.1016/j.cmi.2017.10.005. Epub 2017 Oct 12.

5.

Improved Differentiation of Streptococcus pneumoniae and Other S. mitis Group Streptococci by MALDI Biotyper Using an Improved MALDI Biotyper Database Content and a Novel Result Interpretation Algorithm.

Harju I, Lange C, Kostrzewa M, Maier T, Rantakokko-Jalava K, Haanperä M.

J Clin Microbiol. 2017 Mar;55(3):914-922. doi: 10.1128/JCM.01990-16. Epub 2017 Jan 4.

6.

Whole genome analysis of Mycobacterium tuberculosis isolates from recurrent episodes of tuberculosis, Finland, 1995-2013.

Korhonen V, Smit PW, Haanperä M, Casali N, Ruutu P, Vasankari T, Soini H.

Clin Microbiol Infect. 2016 Jun;22(6):549-54. doi: 10.1016/j.cmi.2016.03.014. Epub 2016 Mar 26.

7.

Enhanced tuberculosis outbreak investigation using whole genome sequencing and IGRA.

Smit PW, Vasankari T, Aaltonen H, Haanperä M, Casali N, Marttila H, Marttila J, Ojanen P, Ruohola A, Ruutu P, Drobniewski F, Lyytikäinen O, Soini H.

Eur Respir J. 2015 Jan;45(1):276-9. doi: 10.1183/09031936.00125914. Epub 2014 Oct 16. No abstract available.

8.

Genotypic characterization and historical perspective of Mycobacterium tuberculosis among older and younger Finns, 2008-2011.

Smit PW, Haanperä M, Rantala P, Couvin D, Lyytikäinen O, Rastogi N, Ruutu P, Soini H.

Clin Microbiol Infect. 2014 Nov;20(11):1134-9. doi: 10.1111/1469-0691.12725.

9.

Molecular epidemiology of tuberculosis in Finland, 2008-2011.

Smit PW, Haanperä M, Rantala P, Couvin D, Lyytikäinen O, Rastogi N, Ruutu P, Soini H.

PLoS One. 2013 Dec 26;8(12):e85027. doi: 10.1371/journal.pone.0085027. eCollection 2013.

10.

Evaluation of two matrix-assisted laser desorption ionization-time of flight mass spectrometry systems for identification of viridans group streptococci.

Kärpänoja P, Harju I, Rantakokko-Jalava K, Haanperä M, Sarkkinen H.

Eur J Clin Microbiol Infect Dis. 2014 May;33(5):779-88. doi: 10.1007/s10096-013-2012-8. Epub 2013 Nov 8.

PMID:
24202732
11.

Interactions between Bordetella pertussis and the complement inhibitor factor H.

Amdahl H, Jarva H, Haanperä M, Mertsola J, He Q, Jokiranta TS, Meri S.

Mol Immunol. 2011 Jan;48(4):697-705. doi: 10.1016/j.molimm.2010.11.015. Epub 2010 Dec 16.

PMID:
21167605
12.

Typing of SHV extended-spectrum beta-lactamases by pyrosequencing in Klebsiella pneumoniae strains with chromosomal SHV beta-lactamase.

Haanperä M, Forssten SD, Huovinen P, Jalava J.

Antimicrob Agents Chemother. 2008 Jul;52(7):2632-5. doi: 10.1128/AAC.01259-07. Epub 2008 May 5.

13.

Immunity to pertussis 5 years after booster immunization during adolescence.

Edelman K, He Q, Mäkinen J, Sahlberg A, Haanperä M, Schuerman L, Wolter J, Mertsola J.

Clin Infect Dis. 2007 May 15;44(10):1271-7. Epub 2007 Apr 2.

PMID:
17443462
14.

Identification of alpha-hemolytic streptococci by pyrosequencing the 16S rRNA gene and by use of VITEK 2.

Haanperä M, Jalava J, Huovinen P, Meurman O, Rantakokko-Jalava K.

J Clin Microbiol. 2007 Mar;45(3):762-70. Epub 2007 Jan 10.

15.

Bordetella holmesii DNA is not detected in nasopharyngeal swabs from Finnish and Dutch patients with suspected pertussis.

Antila M, He Q, de Jong C, Aarts I, Verbakel H, Bruisten S, Keller S, Haanperä M, Mäkinen J, Eerola E, Viljanen MK, Mertsola J, van der Zee A.

J Med Microbiol. 2006 Aug;55(Pt 8):1043-51.

PMID:
16849724
16.
17.

Pertussis-specific cell-mediated and humoral immunity in adolescents 3 years after booster immunization with acellular pertussis vaccine.

Edelman KJ, He Q, Makinen JP, Haanpera MS, Tran Minh NN, Schuerman L, Wolter J, Mertsola JA.

Clin Infect Dis. 2004 Jul 15;39(2):179-85. Epub 2004 Jul 2.

PMID:
15307026
18.

Antimicrobial susceptibility patterns and macrolide resistance genes of viridans group streptococci from normal flora.

Seppälä H, Haanperä M, Al-Juhaish M, Järvinen H, Jalava J, Huovinen P.

J Antimicrob Chemother. 2003 Oct;52(4):636-44. Epub 2003 Sep 12.

PMID:
12972451

Supplemental Content

Loading ...
Support Center